Patients with medically unresponsive trigeminal neuralgia (TN) who are .70 years of age often undergo operations that typically provide pain relief for ,5 years despite having a life expectancy that can exceed 15 years. OBJECTIVE: To review the safety and efficacy of posterior fossa exploration (PFE) for TN patients . 70 years of age. METHODS: From 1999 to 2009, 67 TN patients .70 years of age (median, 74 years) underwent a PFE. Thirty-seven patients (55%) had failed $1 prior surgeries (median, 2). Fifty-nine patients (88%) had a microvascular decompression, and 8 patients (12%) underwent a partial sensory rhizotomy. Follow-up (median, 40 months) was censored at the time of last contact (n = 51), additional surgery (n = 12), or death (n = 4). RESULTS: Complete pain relief (no pain, no medications) was 87% at 1 year and 78% at 5 years. Facial pain outcomes did not correlate with patient age, sex, prior surgery, or pain duration. Postoperative complications were noted in 10 patients (15%) and included ataxia (10%), hearing loss (5%), trigeminal dysesthesias (5%), facial weakness (3%), aseptic meningitis (2%), and pulmonary embolus (2%). Factors associated with postoperative complications were prior PFE (P = .01) and neurovascular compression from a dolicoectatic basilar artery (P = .03). CONCLUSION: Posterior fossa exploration is safe and effective for physiologically healthy TN patients .70 years of age. It should be deferred in older patients with TN secondary to a dolicoectatic basilar artery and patients who have persistent/recurrent pain after a previous PFE unless simpler procedures prove ineffective at controlling their facial pain.
T rigeminal neuralgia (TN) is characterized by typically unilateral, severe, recurrent pain in $ 1 divisions of the trigeminal nerve. Although earlier studies found an incidence of ,5 per 100 000 patient-years, 1 more recent epidemiological studies have noted TN to be more common, with incidence rates from 12.6 to 28.9 per 100 000 patient-years. [2] [3] [4] Common findings in these reports are that TN is more frequent in women than men and that the incidence increases with age. A registry of Dutch general practitioners from 1996 to 2003 found the incidence of TN to be 88.4 per 100 000 patient-years for women and 74.2 per 100 000 patient-years for men .75 years of age. 2 Medical therapy with carbamazepine (Level A evidence) or oxcarbamazepine (Level B evidence) has proven to be effective in controlling facial pain for patients with idiopathic TN, whereas the evidence supporting either the timing or type of surgery for patients with medically intractable TN is of lower quality. 5 Nonetheless, most neurosurgeons agree that a microvascular decompression (MVD) is the preferred surgical approach for patients with medically unresponsive, idiopathic TN. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] In this study, we review the facial pain outcomes and complications for patients . 70 years of age having a posterior fossa exploration (PFE) for idiopathic TN.
PATIENTS AND METHODS

Patients
From July 1999 to December 2009, the senior author (B.E.P.) performed 315 PFEs for patients with idiopathic TN. Seventy-two patients (23%) were $ 70 years of age at the time of their surgery. All aspects of this study were approved by the Mayo Clinic Institutional Review Board. In accordance with Minnesota State statutes, living patients were required to consent to review of their medical records. No patient refused research authorization. Five patients were excluded because they had ,6 months of follow-up. The characteristics of the remaining 67 patients are outlined in the Table. Of note, only 2 patients (3%) had Burchiel type 2 TN. 16 
Surgical Technique
Patients were operated on in a lateral position with intraoperative monitoring of brainstem auditory evoked potentials. 17 An MVD was performed whenever a significant compression of the trigeminal nerve was noted (n = 59, 88%). The superior cerebellar artery alone (n = 20), in combination with the anterior inferior cerebellar artery (n = 4), or in combination with an adjacent vein (n = 18) was the most frequent operative finding. Neurovascular compression was also noted by the vertebrobasilar (VB) system (n = 5), anterior inferior cerebellar artery (n = 5), or venous compression alone (n = 5). Compression by a previously placed prosthesis was found in 2 patients. A partial sensory rhizotomy (PSR) was performed with division of the inferior one-third to one-half of portio major in 8 patients (12%) because no compressing lesions were noted (n = 6) or a compression by the VB system could not be performed effectively (n = 2). The median hospital length of stay was 3 days (range, 1-8 days).
Follow-up and Statistical Analysis
Patient outcomes were assessed at the time of hospital discharge and then yearly thereafter to assess facial pain outcome. Preoperative characteristics, operative findings, complications, and facial pain outcomes were maintained in a prospective database. Facial pain outcomes were classified as excellent (absence of facial pain without medications for TN), good (complete pain relief but still requiring a low dosage of medications), fair (continued facial pain but reduced .50% compared with before surgery), and poor. Patient follow-up was censored at last contact (n = 51), time of subsequent surgery (n = 12), or death (n = 4). The median follow-up was 40 months (range, 1 week-110 months).
Kaplan-Meier curves were calculated to determine the percentage of patients who were pain free off medications after surgery. Differences in facial pain outcomes were tested by log-rank methods. Factors analyzed for achieving and maintaining an excellent facial pain outcome and postoperative complications included patient age (#74 vs .74 years), patient age (continuous variable), sex, pain location, type of TN (Burchiel type 1 vs 2), pain duration, prior surgery (any type), prior MVD, operative findings, and new trigeminal deficits. Univariate comparisons of continuous variables were compared by use of the Student t test; proportional differences were compared by the x 2 test.
RESULTS
Facial Pain Outcomes
Facial pain outcomes at the time of hospital discharge were excellent in 65 patients (97%), fair in 1 patient, and poor in 1 patient. Eleven patients (16%) developed recurrent pain at a median of 10 months after surgery (range, 2-95 months). Complete pain relief (no pain, no medications) was 87% at 1 year and 78% at 5 years ( Figure) . Facial pain outcomes did not correlate with any tested factor, including age as a continuous or dichotomized variable. Twelve patients (18%) underwent additional surgery during the follow-up interval, including repeat PFE (n = 2), glycerol rhizotomy (n = 5), and stereotactic radiosurgery (n = 5). FIGURE. Actuarial graph showing the number of patients pain free off medications after posterior fossa exploration. The numbers of patients being followed up at 1, 3, and 5 years were 53, 37, and 17, respectively.
Complications New (n = 10) or worsened (n = 5) trigeminal deficits were noted in 15 patients (22%) after surgery. New trigeminal deficits were noted in all patients undergoing a PSR and in 7 of 59 patients (12%) having an MVD. Subjective, nonbothersome facial numbness or paresthesias were described by 12 patients (18%), whereas 3 patients (5%) developed dysesthetic facial pain. Dysesthetic facial pain occurred in 3 of 8 patients undergoing a PSR. No patient having an MVD developed dysesthetic facial pain.
Postoperative complications were noted in 10 patients (15%; including patients with dysesthetic facial pain). Additional postoperative complications included ataxia (n = 7, 10%), hearing loss (n = 3, 5%), facial weakness (n = 2, 3%), aseptic meningitis (n = 1, 2%), and pulmonary embolus (n = 1, 2%). Factors associated with postoperative complications were prior PFE (P = .01) and VB compression (P = .03). Notably, patient age did not correlate with postoperative complications. The complication rate in patients without a prior PFE or VB compression was 8% (4 of 52 patients). The hospital length of stay was significantly longer in patients with complications (median length of stay, 5 vs 3 days; P , .001). Four patients (6%) were discharged to either an in-patient rehabilitation unit (n = 2) or a skilled nursing facility (n = 2) primarily related to their ataxia and safety concerns. All had returned to independent ambulation without assistance at the last follow-up.
DISCUSSION
Rationale for PFE in Older Patients
The impact of increasing life expectancies on health care has been a topic of great debate. 18 In developed countries, it has been noted that the period of morbidity, defined as the amount of time an individual has a given condition, is increasing for many diseases related to earlier diagnosis and longer life expectancies. The challenge of physicians then is to increase the life expectancy in good health so that patients are not just living longer but also living better. Trigeminal neuralgia is associated with severe pain that is described as excruciating, causing patient impairment if the pain cannot be effectively managed by medical therapy or surgery. Tölle and colleagues 19 conducted an observational study of 82 TN patients using a detailed questionnaire that included pain severity, functional status, and questions related to current treatment, health status, and resource use. Patients reported a mean Pain Severity Index of 4.2 (range, 1-10), indicating moderate pain despite the vast majority (94%) using medical therapy to treat their TN. Pain severity was associated with reduced daily functioning and poor health status. More than one-third of employed patients stated that TN adversely affected their working status in terms of reduced hours, disability, or early retirement.
The Social Security Administration recently provided the actuarial life expectancies in the United States from 2006. 20 At 70 years of age, the average survival of men and women was 13.6 and 15.9 years, respectively. Life expectancy declines to 7.8 and 9.3 years for men and woman at 80 years of age but does not become , 5 years until patients are . 85 years. As an alternative to MVD for patients with medically unresponsive TN, a number of less invasive options are available, including various percutaneous needle-based techniques [21] [22] [23] [24] [25] [26] and stereotactic radiosurgery. [27] [28] [29] [30] [31] [32] Review of facial pain outcomes from these ablative procedures shows that patients typically are pain free for 3 to 5 years and that additional procedures are frequently necessary. 33 Consequently, if a TN patient is physiologically healthy but .70 years of age, does it not make sense to perform an MVD that will likely provide durable pain relief rather than procedures with an expected benefit of only a few years if a patient's life expectancy is .1 decade?
Outcomes From MVD in the Elderly
A number of studies have reported that MVD in older patients is both safe and effective. 6, 8, 9, 11, 12 Günther et al 9 compared outcomes and morbidity for 112 patients .65 years of age (mean age, 70.4 years) with those of 250 patients ,65 years of age (mean age, 54 years) with medically refractory TN. In this series, there was no difference in the surgical complication rate or longterm facial pain outcomes between the 2 groups. The most frequent neurological morbidity in the older patient group was hearing loss (6.3%) or trigeminal deficits (6.3%), and 75% of patients were pain free without medications at the last follow-up (mean, 90 months). Ferroli et al 8 performed a similar analysis comparing the results of MVD for patients ,65 years (n = 359) and patients .65 years (n = 117) of age. The mean age of the older group was 69.2 years (range, 65-82 years). It was not stated whether any patients had undergone prior operations or had a constant pain component. At a mean of 3.8 years after surgery, 85% of patients .65 years of age had complete pain relief. There was no difference in hearing loss (5.7% vs 6.3%) or facial sensory loss (5.8% vs 5.3%) between the 2 groups. Sekula et al 12 reported 25 TN patients .75 years of age (mean age, 79.4 years) having an MVD from 2000 and 2003. At an average follow-up of 44 months, 78% of patients were pain free without medications. One patient had a midbrain stroke requiring discharge to an inpatient rehabilitation center. The authors felt that this complication was related to a period of intraoperative hypotension. A more recent prospective series from this same group compared the outcomes and complications of 36 elderly patients (mean age, 73.0 years) with those of 53 nonelderly patients (mean age, 52.9 years). 34 Thirty-one older patients (86%) were pain free at a mean of 20 months after surgery. No difference was noted in pain relief or length of stay between the 2 patient groups. A meta-analysis based on their data and 7 published series including more than 1300 TN patients having an MVD (elderly patients, n = 433; nonelderly patients, n = 901) found no significant increase in the chance of cerebellar hematoma, permanent cranial nerve deficit, stroke, or death between younger and older patients.
Our results confirm that older patients with medically unresponsive TN have outcomes similar to those of younger patients having a PFE and should be considered for this surgery if they are physiologically well. In our series, patient age ranged from 70 to 85 years (median, 74 years), and the majority of patients (55%) had failed $1 prior operations. Complete pain relief (no pain, no medications) was 87% at 1 year and 78% at 5 years. Two postoperative complications were more frequent than generally reported after MVD for TN and are worthy of further discussion. First, 7 patients (10%) had ataxia, with 4 patients (6%) being discharged to either a skilled nursing facility or in-patient rehabilitation secondary. These patients typically had nonspecific vestibular dysfunction, and family members expressed safety concerns if they were being released directly to home. At the last follow-up, each had recovered and was independent in their ambulation without assistance. Nonetheless, our experience with this patient group is contrary to that of Ferroli et al 8 and Sekula et al, 12 who stated that older patients can be admitted directly to a regular floor rather than an intensive care unit postoperatively and can frequently be dismissed from the hospital the day after their operation. Second, 3 patients (5%) in our series developed dysesthetic facial pain after surgery. Clearly, one reason to perform an MVD is that pain relief does not require trigeminal injury and the risk of facial deafferentation pain is less with an MVD than simpler percutaneous techniques or stereotactic radiosurgery. Unlike other studies that have reported only patients having an MVD, 7, 9, 13 a PSR was performed in 8 of our 67 patients (12%). Four patients had undergone a previous MVD, and no compressing lesions were noted at surgery; 2 patients had compression by the VB system, which could not be effectively mobilized and retained away from the trigeminal nerve. Dysesthetic facial pain occurred in 3 of 8 patients undergoing a PSR. No patient having an MVD developed dysesthetic facial pain. The factors associated with postoperative complications in our series were prior PFE and neurovascular compression from a dolicoectatic basilar artery. This reinforces the contention of Sekula et al that ''sensory disturbances after MVD are more common with the decompression of dolichoectatic intracranial arteries (for example, the SCA [superior cerebellar artery]), with adhesions to the trigeminal nerve requiring greater manipulation of the trigeminal nerve during decompression, prior ablative procedures, and venous decompression.'' 34 To reduce the complication rate of this surgery and to minimize the chance of performing a PSR, we now obtain specific high-resolution magnetic resonance imaging of patients and will attempt multiple destructive procedures in patients with TN related to a dolichoectatic VB system before recommending a PFE. The other complications noted (hearing loss, facial weakness, aseptic meningitis, pulmonary embolus) were within the range of published series on MVD whose patients were typically ,65 years of age.
CONCLUSION
Patients with medically unresponsive, idiopathic TN should be considered for an MVD on the basis of the quality of their pain, magnetic resonance imaging findings, and physiological health. Older patients who have not undergone a prior PFE or do not have neurovascular compression from a dolichoectatic VB system have facial pain outcomes and postoperative risks similar to those of younger patients.
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